Systemic Contact Dermatitis: Current Challenges and Emerging Treatments
- 3.2k Downloads
Systemic contact dermatitis (SCD) is poorly understood, and its very existence has even been questioned. Allergic contact dermatitis (ACD) is an immune-mediated, delayed-type hypersensitivity (type-IV) reaction, usually manifesting itself as a visible and symptomatic inflammation of the skin. The majority of patients diagnosed with ACD improve clinically with allergen avoidance. The mainstay of avoidance for most allergens is the prevention of skin contact through discontinuation of products that contain the allergen(s), the selection of alternatives from “safe lists,” and counseling patients on environmental sources of allergens. While ACD affects a large percentage of the population, relatively few patients have been documented as having had a significant contribution to their allergic state by allergen exposure through sources other than by cutaneous contact. SCD is defined as provocation or exacerbation of dermatitis by non-cutaneous exposure to an allergen in a patient who is already cutaneously sensitized. Exposure routes in SCD are varied, with the most common and frequently documented being oral exposure. Diet may be an important source of exposure to contact allergens in some patients with ACD, and low-allergen diets have been developed for some common allergens, such as nickel, cobalt, and Balsam of Peru (Myroxylon pereirae). When contact avoidance and dietary restriction of allergen fail, escalation from topical treatments to systemic immune-suppressants may be necessary. Emerging therapies such as nickel oral hypo-sensitization may be beneficial in the future.
KeywordsDermatitis Systemic Nickel Cobalt Balsam of Peru Myroxylon pereirae Chromate Formaldehyde Propylene glycol Compositae Parabens Sorbic acid Allergic contact dermatitis Disulfuram Hyposensitization Allergy Diet Food Systemic contact dermatitis Allergen Avoidance diet Elimination diet Aspartame
Allergic contact dermatitis (ACD) has an approximate prevalence of 20 % . We do not know the exact prevalence of systemic contact dermatitis (SCD), but it is thought to be much less common. While most sensitized patients improve with cutaneous allergen avoidance, others require avoidance of systemic sources, such as a specialized diet to also limit oral exposure to allergens. Low-allergen diets have been developed for specific common allergens, and these diets are recommended in practice when necessary. Early reports of somewhat successful hypo-sensitization are being revisited, with the potential for future therapy.
The incidence and prevalence of ACD in the general population has been difficult to study. A thoughtful review by Thyssen et al., in 2007 estimated the median prevalence of contact allergy in the general population as 21.2 %, with a weighted average prevalence of 19.5 %. The most common allergens noted were nickel, thimerosal, and fragrance mix. The median nickel allergy prevalence was noted to be 8.6 % .
Unfortunately, no epidemiological data exist for SCD in the general population. Challenges in the collection of this information include the large number of allergens that can cause SCD, the clinical basis for the diagnosis of SCD, and the diversity of clinical presentations of SCD. However, a meta-analysis of 17 studies of oral nickel exposure estimated that 1 % of nickel-sensitive patients may react systemically to everyday nickel exposure (0.22– 0.35 mg nickel), and 10 % may react to a diet composed of foods rich in nickel (0.55–1.33 mcg nickel) . Furthermore, European literature has noted the emergence of a “systemic nickel allergy syndrome” or SNAS, defined as nickel-induced SCD with extracutaneous symptoms. Of 1,696 patients referred to allergy units in Italy, 98 (5.78 %) were diagnosed with SNAS .
SCD is defined as non-cutaneous exposure to an allergen causing dermatitis in a person who is already cutaneously sensitized . The pathogenesis of ACD has been well-described, and involves an immune-mediated sensitization and elicitation phase. After sensitization, exposure to the allergen administered through a route other than skin contact is thought to elicit an immune response that produces cutaneous manifestations. Common routes of exposure include oral, intra-articular, intramuscular, intravenous, inhalation, and subcutaneous, among others . While ACD has been described as a type IV delayed-type hypersensitivity, SCD may also involve a type III immune response, as antigen-antibody complexes have been found in the skin , and in the blood , in such reactions.
The clinical presentation of SCD can vary widely. While SCD may be clinically indistinguishable from ACD, unique presentations are also recognized. Baboon syndrome has been used to describe a SCD manifesting as erythema of the buttocks and flexural skin . If this presentation is drug-related, it has been denoted symmetric drug-related intertriginous and flexural exanthema (SDRIFE) . Vesicular hand (and possibly foot) dermatitis has also been described and is most commonly associated with metals, specifically oral administration of nickel, cobalt and chromium [10, 11, 12, 13, 14, 15], as can the ingestion of spices . Similarly, perianal dermatitis [17, 18] and “recall” dermatitis, reactivation of a patch test site [19, 20] or of prior dermatitis [21, 22], have been ascribed to SCD.
The epicutaneous patch test remains the gold standard for diagnosing ACD. When patients do not clinically improve with prescribed topical avoidance of relevant allergens, SCD should be added to the differential diagnosis. Certain allergens are more likely than others to cause SCD, and consideration of the potential relevance of non-cutaneous sources of exposure should be undertaken. The diagnosis of SCD is supported when a patient improves after avoidance of exposure by oral or another route to the proven allergen. Typically, re-challenge of a patient with this allergen via the non-cutaneous route helps confirm the diagnosis.
With regard to oral exposure, ability to adhere to a diet may impact the prognosis of a patient with SCD. Some diets are more difficult to follow than others, and individual patient preference for foods may also affect success or failure with prescribed low-allergen diets. Additionally, individuals may have different thresholds of response, and some more sensitive patients may have to adhere more stringently than others to control symptoms.
- SCD with oral allergen exposure is managed with dietary avoidance (Table 1). Poor compliance or inability to maintain restriction in the setting of persistent symptoms may merit consideration of phototherapy or immunosuppressant therapy. Oral hypo-sensitization has been reported as a possible future treatment for the systemic nickel allergy syndrome (SNAS) subgroup of patients.Table 1
Diet-related allergens associated with systemic contact dermatitis
Balsam of Peru (Myroxylon pereirae)
- An algorithmic approach to management of dermatitis in a patient with clinically relevant positive epicutaneous patch test can be found in Fig. 1.
Diet and lifestyle
A points-based nickel diet system has been developed to assist with adherence to nickel dietary restriction. This system allocates gradations of points from 0 to 10 based on the amount of nickel found in the food. Adults are allocated 15 points daily to “spend” on foods listed, children under 12 are allocated 10 points daily, and very sensitive individuals should be restricted to 5 points daily. It is recommended that foods containing beans, granola, chocolate, peanuts, soy, and oatmeal be avoided altogether, given their very high nickel content [24••].
Water can also be a source of nickel. Drinking bottled or distilled water [24••] may be helpful. Alternatively, if the water has been sitting in the pipes for some time, a few liters should be expelled before consumption or use, as nickel can leach into the water from the pipes .
Cooking in stainless steel pots and pans should be avoided, as nickel can leach into foods. Acidic foods such as citrus, tomato-based meals, and vinegar may also contribute to this phenomenon . Similarly, stainless steel utensils should not be used while cooking acidic foods .
Both processed foods and canned foods may have higher than expected nickel content due to packaging and processing equipment .
The soil in which a food is grown may affect the food’s nickel content .
Absorption of nickel may vary depending on patient health and overall diet. Vitamin C  and iron  decrease the dietary absorption of nickel . Taking a chewable 500 mg or 1000 mg vitamin C tablet with food at every meal may decrease absorption of nickel [24••]. Patients with iron-deficiency anemia may absorb more nickel from the diet than expected [27, 32]. Avoidance of any nickel-containing multivitamin is recommended [24••].
If constipation occurs following a low-nickel diet, taking a stool softener such as docusate sodium may be helpful [24••].
Cobalt is a constituent of vitamin B12. Naturally occurring B12, comprised of adenosylcobalamin and methylcobalamin, does not cause hypersensitivity reactions . However, there are reports of reactions to synthetically derived B12, both cyanocobalamin and hydroxycobalamin [33, 34].
It is thought that it is the cobalt itself, rather than the vitamin B12 in foods, that contributes to SCD .
A low-cobalt points-driven diet has been developed to facilitate dietary cobalt restriction. Patients are limited to 12 points daily, and portioned foods are assigned a point value of 1–7 depending on cobalt content .
Brazil nuts, cow liver and herbal/homeopathic remedies are not permitted on this diet due to elevated cobalt levels .
Contributions to the overall cobalt exposure burden include smoking and industrial sources .
Avoiding foods high in chromate may be necessary in chromium-sensitive patients . These foods include red wine , whole grains and bran, potatoes, meats, fruits such as apples and bananas, orange and grape juice, beans and nuts, vegetables such as broccoli and green beans, brewer’s yeast, black pepper, coffee and tea [38, 39, 40].
Canned food, hard water, and chromium-containing drinks and supplements should be avoided .
Cooking in aluminum cookware decreases the chromium content of food while using stainless steel cookware increases the chromium content .
Foods containing simple sugars, such as fructose and sucrose, may help eliminate chromium .
Balsam of Peru (BOP)
BOP (Myroxylon pereirae) is a commonly used fragrant sap-derived substance from a tree in Central America. It consists of a conglomerate of numerous potential allergens, including vanillin, cinnamates, benzoates, ferulic acid, coniferin, and eugenol subgroups [41••].
Numerous foods may contain spices and flavorings problematic for individuals sensitized to BOP or any of its many components. On a low-BOP diet, it is important to avoid citrus (including essence, oil, and peel); sweet baked goods; spices such as cinnamon, cloves, vanilla, curry, allspice, anise, and ginger; pickled foods; tomato-based sauces; spicy condiments; select alcohols such as certain wines, gin and vermouth; chocolate; ice cream; and flavored soft drinks, including colas. Any spiced tobacco or medicinal product should also be avoided .
It is likely that not all patients with BOP-related systemic contact dermatitis need to avoid all subgroups, and Scheman et al. [41••] recommend further classification and testing for the subgroups eugenol, vanillin, cinnamates, benzoates, ferulic acid, and coniferin. Knowing the specific BOP allergen subgroup(s) can help identify more specific foods to avoid, rather than eliminating the broad list above [41••].
Avoidance of consumable members of the Compositae family may be necessary, including chamomile tea, lettuce, echineacea, chicory, and endive .
Sorbates are preservatives found in prepackaged foods and should be listed on the label if present. Some prepackaged dairy and meat products contain sorbates, as can selected cereals, juice, prepared drinks and soda, condiments, ice cream, and many desserts [43••].
When dietary avoidance is not practical or possible, systemic immune-suppressants such as azathioprine, cyclosporine, methotrexate, and mycophenolate mofetil may be considered after a trial of topical steroids or calcineurin inhibitors if appropriate [49•]. Disulfiram has been used rarely in nickel systemic contact allergy with some success, but it remains a nonconventional therapy [49•]. Primarily used in treatment for alcohol addiction, disulfiram is metabolized by the liver into sodium diethyldithiocarbamate, which in turn chelates nickel and cobalt. Increased excretion of nickel ensues via bile, urine, and sweat [50, 51]. Multiple studies have confirmed improvement in recalcitrant nickel-sensitive patients with use of disulfiram [49•].
The use of ultraviolet light treatment in hand eczema can be effective . It is also used for localized and diffuse dermatitis. Narrow-band ultraviolet B (NBUVB) light, ultraviolet A (UVA) light, and topical or systemic psoralen with ultraviolet A (PUVA) light are potential options for phototherapy. Contraindications to phototherapy include exogenous or endogenous sun-sensitivity and a personal history of melanoma, while history of nonmelanoma skin cancer is a relative contraindication.
Hypo-sensitization is an emerging treatment in the field of systemic allergic contact dermatitis. Oral hypo-sensitization has been reported to have had some success in the treatment of cobalt-sensitive , and nickel-sensitive patients [54•, 55].
A recently published randomized, double-blind, placebo-controlled trial addressed patients with a diagnosis of SNAS. These patients had not only skin symptoms, but also extracutaneous complaints, commonly gastrointestinal, which were associated with nickel consumption. The group treated with the highest dose of nickel weekly was able to tolerate re-introduction of nickel-rich foods better than the placebo group, and required less use of rescue medications. Higher nickel doses after treatment were required to elicit a symptomatic flare as compared to pre-treatment. Gastrointestinal symptoms were statistically significantly improved in this same group as compared to placebo; skin symptoms were improved, though not statistically significantly [54•].
The mechanism of hypo-sensitization is still being investigated. Following nickel oral hypo-sensitization therapy, there are cytokine changes from a primarily Th2 profile to an increase in IL-10 , which is a regulatory cytokine . Cavani et al.  postulate that the proliferation and differentiation of T regulatory cells may lead to increased tolerance of nickel after hypo-sensitization therapy.
Compared to adults, children may have similar oral exposure to contact allergens, with the exception of fewer medication exposures [59•]. Special considerations in children include repeated or high consumption of particular foods or condiments, such as ketchup . Adherence to a low-allergen diet may require both patient and parent involvement.
Compliance with Ethics Guidelines
Conflict of Interest
Heather P. Lampel declares that she has no conflict of interest.
Dianne L. Silvestri declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 24.••Mislankar M, Zirwas MJ. Low-nickel diet scoring system for systemic nickel allergy. Dermatitis. 2013;24(4):190–8. This original article serves as a guide for patients following a low-nickel diet. This original article serves as a guide for patients following a low-nickel diet. This points-based low-nickel diet indexes numerous foods in an easy-to-read mannerGoogle Scholar
- 28.Joneja JM. Section III: specific food restrictions: nickel allergy. In: Joneja JM (ed) Managing food allergy and intolerance: a practical guide. JA Hall Publications, Ltd, 2nd ed; 1998.Google Scholar
- 35.Expert Group on Vitamins and Minerals. Review of cobalt. UK Food Standards Agency, 2002.Google Scholar
- 40.Saner G. The metabolic significance of dietary chromium. Nutr Int. 1986;2:213–20.Google Scholar
- 41.••Scheman A, Rakowski E, Chou V, et al. Balsam of Peru: past and future. Dermatitis. 2013;24(4):153–60. This resource classifies balsam of Peru, or Myroxylon pereirae, subgroups in foods. Use of allergen subgroups can help broaden a sensitive patient’s diet, since many patients do not need to avoid all Myroxylon pereirae subgroups, depending on individual sensitivitiesPubMedCrossRefGoogle Scholar
- 52.Robertson L. New and existing therapeutic options for hand eczema. Skin Ther Lett. 2009;14(3):1–5.Google Scholar
- 54.•Di Gioacchino M, Ricciardi L, De Pità O, et al. Nickel oral hyposensitization in patients with systemic nickel allergy syndrome. Ann Med. 2014;46(1):31–7. This is the first published randomized, double-blind, placebo-controlled trial addressing nickel hyposensitization in patients with systemic nickel allergy syndrome. It demonstrates statistically significant improvement in gastrointestinal symptoms in patients, with a trend toward skin symptom improvementPubMedCrossRefGoogle Scholar
- 59.•Matiz C, Jacob SE. Systemic contact dermatitis in children: how an avoidance diet can make a difference. Pediatr Dermatol. 2011;28(4):368–74. These authors report 8 children with systemic contact dermatitis who improve with avoidance diets. Factors specific to pediatric systemic contact allergy are addressed in the articlePubMedCrossRefGoogle Scholar